Want to join the conversation?
The U.S. Food and Drug Administration (FDA) approved $MDT's IN.PACT Admiral drug-coated balloon as a treatment for in-stent restenosis (ISR) in patients with peripheral artery disease. FDA approval was based on ISR data from the IN.PACT Global Study compared to a standard percutaneous balloon angioplasty control.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?